What are the Clinical Implications of Fatty Acid Synthase Dysregulation?
Dysregulation of FAS is implicated in a variety of diseases. In addition to its role in cancer, alterations in FAS activity are linked to metabolic disorders such as obesity, diabetes, and fatty liver disease. Understanding FAS regulation and function in these contexts can lead to the development of therapeutic strategies targeting this enzyme to treat metabolic and proliferative diseases.
